Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 66
Filtrar
Más filtros

Intervalo de año de publicación
1.
Br J Haematol ; 177(5): 674-683, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28106908

RESUMEN

The story of the discovery of aspirin stretches back more than 3500 years to when bark from the willow tree was used as a pain reliever and antipyretic. It involves an Oxfordshire clergyman, scientists at a German dye manufacturer, a Nobel Prize-winning discovery and a series of pivotal clinical trials. Aspirin is now the most commonly used drug in the world. Its role in preventing cardiovascular and cerebrovascular disease has been revolutionary and one of the biggest pharmaceutical success stories of the last century.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Antipiréticos/uso terapéutico , Aspirina/uso terapéutico , Inhibidores de Agregación Plaquetaria/uso terapéutico , Salix , Antiinflamatorios no Esteroideos/historia , Antiinflamatorios no Esteroideos/farmacología , Antipiréticos/historia , Antipiréticos/farmacología , Aspirina/historia , Aspirina/farmacología , Enfermedades Cardiovasculares/historia , Enfermedades Cardiovasculares/prevención & control , Descubrimiento de Drogas/historia , Predicción , Enfermedades Hematológicas/historia , Enfermedades Hematológicas/prevención & control , Hemorragia/inducido químicamente , Hemorragia/historia , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Historia Antigua , Corteza de la Planta , Inhibidores de Agregación Plaquetaria/historia , Inhibidores de Agregación Plaquetaria/farmacología
2.
Blood ; 126(24): 2548-60, 2015 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-26631112

RESUMEN

This year we celebrate Blood's 70th year of publication. Created from the partnership of the book publisher Henry M. Stratton and the prominent hematologist Dr William Dameshek of Tufts School of Medicine, Blood has published many papers describing major advances in the science and clinical practice of hematology. Blood's founding antedated that of the American Society of Hematology (ASH) by more than 11 years and Stratton and Dameshek helped galvanize support for the creation of ASH. In this review, I place the birth of Blood in the context of the history of hematology before 1946, emphasizing the American experience from which it emerged, and focusing on research conducted during World War II. I also provide a few milestones along Blood's 70 years of publication, including: the growth in Blood's publications, the evolution of its appearance, the countries of submission of Blood papers, current subscriptions to Blood, and the evolution of topics reported in Blood's papers. The latter provides a snapshot of the evolution of hematology as a scientific and clinical discipline and the introduction of new technology to study blood and bone marrow. Detailed descriptions of the landmark discoveries reported in Blood will appear in later papers celebrating Blood's birthday authored by past Editors-in-Chief.


Asunto(s)
Hematología/historia , Publicaciones Periódicas como Asunto/historia , Animales , Bibliometría , Fenómenos Fisiológicos Sanguíneos , Transfusión Sanguínea/historia , Europa (Continente) , Enfermedades Hematológicas/historia , Hematología/tendencias , Hematopoyesis , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Leucocitos/fisiología , Medicina Militar/historia , Estados Unidos , Segunda Guerra Mundial
3.
Mol Med ; 20: 381-9, 2014 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-25356751

RESUMEN

Real innovations in medicine and science are historic and singular; the stories behind each occurrence are precious. At Molecular Medicine we have established the Anthony Cerami Award in Translational Medicine to document and preserve these histories. The monographs recount the seminal events as told in the voice of the original investigators who provided the crucial early insight. These essays capture the essence of discovery, chronicling the birth of ideas that created new fields of research; and launched trajectories that persisted and ultimately influenced how disease is prevented, diagnosed and treated. In this volume, the Cerami Award Monograph is by Göran K Hansson, MD, PhD, Karolinska Institute. A visionary in the field of cardiovascular research, this is the story of Dr. Hansson's scientific journey.


Asunto(s)
Predisposición Genética a la Enfermedad , Enfermedades Hematológicas/genética , Investigación Biomédica Traslacional/historia , Distinciones y Premios , Genética de Población/historia , Genómica , Enfermedades Hematológicas/historia , Historia del Siglo XX , Humanos , Medicina Molecular/historia
4.
Zhonghua Yi Shi Za Zhi ; 54(3): 145-149, 2024 May 28.
Artículo en Zh | MEDLINE | ID: mdl-38987005

RESUMEN

Xuezheng Quanji(«¼) written by Sun Guangyu, a doctor in the Ming Dynasty, is the first known book on blood disorders in China. The book mainly deals with bleeding. The book begins with a collection of the Neijing and the treatises of the sages, focusing on systematically summarizing the theories and experiences of the past dynasties in the treatment of bleeding, interspersed with Sun's own opinions.The main part discusses four types of bleeding, summarizing Sun's profound experience in clinical practice, and many of his personal creative opinions.In terms of causes,Sun believed that there are three causes of bleeding and more due to heat. In terms of treatment,he opposed the abuse of bitter cold and attached great importance to nourishing yin and strengthening kidney and proposed four treatment methods of dispelling stasis, nourishing Yin and suppressing Yang, regulating Qi and blood, and tonifying deficiency. He advocated that bleeding should not be treated quickly, and emphasized that the disease should be judged according to the bleeding location and bleeding color to use herbs flexibly.Special attention should be paid to daily life care during and after illness as well.


Asunto(s)
Medicina Tradicional China , Humanos , Medicina Tradicional China/historia , China , Enfermedades Hematológicas/historia , Enfermedades Hematológicas/terapia , Libros/historia , Historia Antigua , Historia Medieval
6.
J Biol Chem ; 286(26): e5-6, 2011 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-21842549

RESUMEN

After developing a blood disorder, Yale Nemerson became interested in hematology. This led to his lifelong study of thrombogenic tissue factor and to his contributions to developing the modern theory of blood coagulation. The two Classic papers reprinted here detail some of Nemerson's studies on coagulation factors IX and VII.


Asunto(s)
Coagulación Sanguínea , Factor IX/metabolismo , Factor VII/metabolismo , Enfermedades Hematológicas/metabolismo , Hematología/historia , Tromboplastina/metabolismo , Animales , Factor IX/historia , Factor VII/historia , Enfermedades Hematológicas/historia , Historia del Siglo XX , Humanos , Tromboplastina/historia
7.
Br J Haematol ; 158(6): 691-9, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22765202

RESUMEN

It is now 75 years since the publication of Sir Austin Bradford Hill's classic textbook on Medical Statistics, and half a century since the formation of the Medical Research Council Working Party on Leukaemia. In the intervening period, trials in haematological malignancies have been at the forefront of cancer research, both in the proportion of patients recruited, and in the adoption of novel trial designs. In this paper, the principles propounded by Hill for reliable evaluation of new treatments are considered and placed in the context of the development and evaluation of novel treatments in the 21st century. Many of the original principles espoused are still highly relevant today, while the emerging heterogeneity of the conditions, both in aetiology and outcome provide their own newer challenges, which are discussed here.


Asunto(s)
Interpretación Estadística de Datos , Enfermedades Hematológicas/historia , Ensayos Clínicos Controlados Aleatorios como Asunto/historia , Intervalos de Confianza , Enfermedades Hematológicas/terapia , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Leucemia/historia , Leucemia/terapia , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Ensayos Clínicos Controlados Aleatorios como Asunto/estadística & datos numéricos , Proyectos de Investigación , Tamaño de la Muestra
8.
Br J Haematol ; 152(5): 543-50, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21241280

RESUMEN

Ernest Beutler was one of the preeminent haematologists of the last half of the 20th and the early 21st century. In a career that spanned six decades, his research interests included such diverse areas as red cell metabolism, blood preservation, glycolipid storage diseases, leukaemias and iron metabolism. Indeed, he was quite different from most of his contemporaries in that his knowledge encompassed not only haematology and not only the medical sciences, but the biological sciences as a whole. He was among the first to describe X chromosome inactivation, and he established the critical link between glucose-6-phosphate dehydrogenase deficiency and drug-induced haemolysis. He was a skilled and innovative clinician, and an early advocate of bone marrow transplantation for the treatment of acute leukaemia. He was a prolific author, with over 800 publications; a long time member of the Editorial Board of Blood; founder of the journal Blood Cells Molecules and Diseases; and an editor of Williams Haematology from the time of its inception. He bequeathed $1 million to the American Society of Haematology to recognise and reward outstanding basic research and its clinical application: a pursuit to which he had committed his life. Indeed, he became an extraordinary exemplar of the bench-to-bedside ethos, which holds that even today, an MD researcher, working with limited means and independent of pharmaceutical companies, can have a great impact on the practice of medicine.


Asunto(s)
Enfermedades Hematológicas/historia , Hematología/historia , Trasplante de Médula Ósea/historia , Alemania , Deficiencia de Glucosafosfato Deshidrogenasa/historia , Enfermedades Hematológicas/genética , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Inactivación del Cromosoma X
9.
Br J Haematol ; 154(4): 441-7, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21726206

RESUMEN

Much has been learned about umbilical cord blood (UCB) since the first human cord blood transplant was performed back in 1988. Cord blood banks have been established worldwide for the collection, cryopreservation and distribution of UCB for allogeneic haematopoietic stem cell transplantation. UCB has now become one of the most commonly used sources of haematopoietic stem cells for allogeneic transplantation. Today, a global network of cord blood banks and transplant centres has been established with a large common inventory, allowing for more than 20000 transplants worldwide in children and adults with severe haematological diseases. Several studies have been published on UCB transplant, assessing risk factors such as cell dose and human leucocyte antigen mismatch. New strategies are ongoing to facilitate engraftment and reduce transplant-related mortality and include the use of reduced-intensity conditioning regimen, intra-bone injection of cord blood cells, double cord blood transplants or ex vivo expansion of cord blood cells. The absence of ethical concern and the unlimited supply of cells explain the increasing interest of using UCB for developing regenerative medicine.


Asunto(s)
Trasplante de Células Madre de Sangre del Cordón Umbilical/historia , Bancos de Sangre/historia , Bancos de Sangre/organización & administración , Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Trasplante de Células Madre de Sangre del Cordón Umbilical/tendencias , Selección de Donante , Enfermedades Hematológicas/historia , Enfermedades Hematológicas/terapia , Histocompatibilidad , Historia del Siglo XX , Historia del Siglo XXI , Humanos
12.
Transfus Med Rev ; 20(4): 315-7, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17066573

RESUMEN

After receiving her BSc from the University of Melbourne, Australia, Marie set sail for England to pursue a career. In London, she worked with Dr P.L. Mollison for 10 years, and together they published many articles in the areas of hemolytic disease of the newborn, red cell survival, red cell preservation, and the identification of new antibodies. In 1957, she married Dr John Crookston and moved to Toronto. In Toronto, she directed and participated in various research projects while acting as a consultant to the Blood Transfusion Laboratory at Toronto General Hospital. Her enthusiasm for the field of Transfusion Medicine, her keen eye, and intellect resulted in many discoveries, both on her own or in collaboration with others. Marie is now retired but is fondly remembered by Blood Transfusionists in Canada and elsewhere.


Asunto(s)
Bancos de Sangre , Antígenos de Grupos Sanguíneos/aislamiento & purificación , Transfusión Sanguínea/historia , Transfusión Sanguínea/métodos , Femenino , Enfermedades Hematológicas/historia , Historia del Siglo XX , Humanos
16.
Artículo en Inglés | MEDLINE | ID: mdl-23921481

RESUMEN

The development of clinical haematology in Macedonia has taken place over the past nine decades. The greatest expansion of its development took place in the second half of the 20th century. The oficial start of clinical haematology dates from 1956, when the Department of Haematology was founded within the framework of the Internal Medicine Clinic in Skopje. In the beginning, haematology represented a form of virtual sub-specialty, but its expansion was so progressive and rapid that it reached the highest peaks of Yugoslav haematology in those times. The period from 1968 to 1979 was a period of integral development of haematology and blood-transfusion science in Macedonia. Nowadays, the autonomous Public Health Institution, the University Hematology Clinic, is a unique healthcare, educational and scientific establishment in the Republic of Macedonia in its field of work. The diagnostics algorithm comprises cyto-morphologic and cyto-chemical analysis, through immunologic characterization with the assistance of a flow cytometer, to sophisticated molecular analysis for detecting genetic abnormalities. The therapeutic approach is based upon modern poly-haemotherapeutic protocols, application of monoclonal antibodies, immuno-modulatory agents, molecular target therapy and the use of alogeneic and autologous transplantation of fresh bone-marrow and frozen haemopoietic stem-cells. The current motto of the Haematology Clinic is: always help those who seek help, provide precise and early diagnostics, and apply all up-to-date therapeutic strategies, scientific research, continual education and day-to-day implementation of the latest achievements in the field of haematology in daily practice.


Asunto(s)
Centros Médicos Académicos/organización & administración , Alergia e Inmunología/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Enfermedades Hematológicas , Servicio Ambulatorio en Hospital/organización & administración , Neumología/organización & administración , Centros Médicos Académicos/historia , Alergia e Inmunología/educación , Alergia e Inmunología/historia , Prestación Integrada de Atención de Salud/historia , Educación Médica/organización & administración , Enfermedades Hematológicas/diagnóstico , Enfermedades Hematológicas/historia , Enfermedades Hematológicas/terapia , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Servicio Ambulatorio en Hospital/historia , Neumología/educación , Neumología/historia , República de Macedonia del Norte
19.
Biodemography Soc Biol ; 58(2): 116-32, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23137077

RESUMEN

The Rh-negative gene is a well-known cause of perinatal mortality. In this article, we analyze the possible role of Rh disease in perinatal mortality and stillbirths in a particular historical setting: the Skellefteå region in northern Sweden between 1860 and 1900. The data used for the study cover 23,067 children born to 4,943 women. The exact impact is not possible to establish using historical data, but the typical pattern of the disease allows us to make estimations. The expected levels based on knowledge of blood group distribution, the risk of sensitization from Rh incompatability, and the risk of perinatal mortality in births by sensitized mothers are compared with the observed levels. The results show that Rh disease was important for perinatal mortality and clustering of deaths within families.


Asunto(s)
Demografía/historia , Familia/historia , Enfermedades Hematológicas/historia , Mortalidad Perinatal/historia , Mortinato/epidemiología , Análisis por Conglomerados , Demografía/estadística & datos numéricos , Femenino , Enfermedades Hematológicas/mortalidad , Historia del Siglo XIX , Humanos , Paridad , Embarazo , Sistema del Grupo Sanguíneo Rh-Hr/genética , Sistema del Grupo Sanguíneo Rh-Hr/historia , Factores de Riesgo , Suecia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA